semsem personal page - To The Moon

semsem

semsem

No personal profile

147Follow

6Followers

1Topic

0Badge

2021-08-21

That's wonderful ?

Sorry, the original content has been removed

2021-08-21

That's wonderful

Sorry, the original content has been removed

2021-08-20

Good

Sorry, the original content has been removed

2021-06-03

Cool

Zoom Earnings Beat Expectations: 5 Key Metrics You Should See

2021-06-02

Wonderful ?

AMC Stock Is Surging Again. How to Make Sense of the Move.

2021-08-21

I think that's totally right

Sorry, the original content has been removed

2021-08-21

That's good

Sorry, the original content has been removed

2021-08-02

That's really good ?

Sorry, the original content has been removed

2021-06-21

Ok

Orphazyme rose more than 6% in premarket trading

2021-09-13

$Jamf Holding(JAMF)$wise choice to earn money

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582710052830337","uuid":"3582710052830337","gmtCreate":1619616030501,"gmtModify":1625194768856,"name":"semsem","pinyin":"semsem","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":147,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":261286764417320,"gmtCreate":1704801078398,"gmtModify":1704801083228,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Let's sjare what's the best to invest those days because it's really not clear, we want to exchange the experience together&nbsp;","listText":"Let's sjare what's the best to invest those days because it's really not clear, we want to exchange the experience together&nbsp;","text":"Let's sjare what's the best to invest those days because it's really not clear, we want to exchange the experience together","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261286764417320","isVote":1,"tweetType":1,"viewCount":3068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":256832574029872,"gmtCreate":1703737256113,"gmtModify":1703737260352,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"What's the best today?","listText":"What's the best today?","text":"What's the best today?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256832574029872","isVote":1,"tweetType":1,"viewCount":2823,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9962524115,"gmtCreate":1669811856237,"gmtModify":1676538248088,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Good 👍","listText":"Good 👍","text":"Good 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9962524115","repostId":"1121046362","repostType":4,"repost":{"id":"1121046362","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1669801302,"share":"https://ttm.financial/m/news/1121046362?lang=en_US&edition=fundamental","pubTime":"2022-11-30 17:41","market":"us","language":"en","title":"CrowdStrike, XPeng, Salesforce, Workday And More: U.S. Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=1121046362","media":"Benzinga","summary":"With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab inv","content":"<html><head></head><body><p>With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:</p><ul><li><b>CrowdStrike Holdings Inc</b> forecast fourth-quarter revenue below Wall Street estimates, as an economic downturn hit spending for its cyber security services. Shares of the Austin, Texas-based company tumbled 20.9% to $109.12 in premarket trading Wednesday.</li></ul><ul><li>Wall Street expects <b>XPeng</b> to report quarterly earnings at $-0.36 per share on revenue of $1.01 billion <i>before the opening</i> bell. XPeng shares jumped 12.5% to $8.26 in premarket trading Wednesday.</li></ul><ul><li>Analysts are expecting <b>Salesforce, Inc.</b> to have earned $1.21 per share on revenue of $7.82 billion for the latest quarter. The company will release earnings after the markets close. Salesforce shares rose 0.7% to $152.75 in premarket trading Wednesday.</li></ul><ul><li><b>Workday, Inc.</b> reported better-than-expected earnings for its third quarter on Tuesday. Workday shares jumped 8.5% to $155.50 in the after-hours trading session Tuesday.</li></ul><ul><li>Wall Street expects <b>Hormel Foods Corporation</b> to report quarterly earnings at $0.50 per share on revenue of $3.38 million <i>before the opening</i> bell. Hormel Foods shares fell 0.6% to $47.90 in after-hours trading Tuesday.</li></ul><ul><li><b>Hewlett Packard Enterprise Company</b> posted upbeat results for its fourth quarter and issued strong forecast for the first quarter. Hewlett Packard Enterprise shares gained 3.5% to $16 in premarket trading Wednesday.</li><li>Analysts expect <b>Donaldson Company, Inc.</b> to post quarterly earnings at $0.71 per share on revenue of $827.04 million before the opening bell. Donaldson shares dropped 2.7% to $57.58 in after-hours trading Tuesday.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CrowdStrike, XPeng, Salesforce, Workday And More: U.S. Stocks To Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrowdStrike, XPeng, Salesforce, Workday And More: U.S. Stocks To Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-11-30 17:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:</p><ul><li><b>CrowdStrike Holdings Inc</b> forecast fourth-quarter revenue below Wall Street estimates, as an economic downturn hit spending for its cyber security services. Shares of the Austin, Texas-based company tumbled 20.9% to $109.12 in premarket trading Wednesday.</li></ul><ul><li>Wall Street expects <b>XPeng</b> to report quarterly earnings at $-0.36 per share on revenue of $1.01 billion <i>before the opening</i> bell. XPeng shares jumped 12.5% to $8.26 in premarket trading Wednesday.</li></ul><ul><li>Analysts are expecting <b>Salesforce, Inc.</b> to have earned $1.21 per share on revenue of $7.82 billion for the latest quarter. The company will release earnings after the markets close. Salesforce shares rose 0.7% to $152.75 in premarket trading Wednesday.</li></ul><ul><li><b>Workday, Inc.</b> reported better-than-expected earnings for its third quarter on Tuesday. Workday shares jumped 8.5% to $155.50 in the after-hours trading session Tuesday.</li></ul><ul><li>Wall Street expects <b>Hormel Foods Corporation</b> to report quarterly earnings at $0.50 per share on revenue of $3.38 million <i>before the opening</i> bell. Hormel Foods shares fell 0.6% to $47.90 in after-hours trading Tuesday.</li></ul><ul><li><b>Hewlett Packard Enterprise Company</b> posted upbeat results for its fourth quarter and issued strong forecast for the first quarter. Hewlett Packard Enterprise shares gained 3.5% to $16 in premarket trading Wednesday.</li><li>Analysts expect <b>Donaldson Company, Inc.</b> to post quarterly earnings at $0.71 per share on revenue of $827.04 million before the opening bell. Donaldson shares dropped 2.7% to $57.58 in after-hours trading Tuesday.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HPE":"慧与科技","WDAY":"Workday","XPEV":"小鹏汽车","HRL":"荷美尔","DCI":"唐纳森","CRM":"赛富时","CRWD":"CrowdStrike Holdings, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121046362","content_text":"With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:CrowdStrike Holdings Inc forecast fourth-quarter revenue below Wall Street estimates, as an economic downturn hit spending for its cyber security services. Shares of the Austin, Texas-based company tumbled 20.9% to $109.12 in premarket trading Wednesday.Wall Street expects XPeng to report quarterly earnings at $-0.36 per share on revenue of $1.01 billion before the opening bell. XPeng shares jumped 12.5% to $8.26 in premarket trading Wednesday.Analysts are expecting Salesforce, Inc. to have earned $1.21 per share on revenue of $7.82 billion for the latest quarter. The company will release earnings after the markets close. Salesforce shares rose 0.7% to $152.75 in premarket trading Wednesday.Workday, Inc. reported better-than-expected earnings for its third quarter on Tuesday. Workday shares jumped 8.5% to $155.50 in the after-hours trading session Tuesday.Wall Street expects Hormel Foods Corporation to report quarterly earnings at $0.50 per share on revenue of $3.38 million before the opening bell. Hormel Foods shares fell 0.6% to $47.90 in after-hours trading Tuesday.Hewlett Packard Enterprise Company posted upbeat results for its fourth quarter and issued strong forecast for the first quarter. Hewlett Packard Enterprise shares gained 3.5% to $16 in premarket trading Wednesday.Analysts expect Donaldson Company, Inc. to post quarterly earnings at $0.71 per share on revenue of $827.04 million before the opening bell. Donaldson shares dropped 2.7% to $57.58 in after-hours trading Tuesday.","news_type":1,"symbols_score_info":{"DCI":0.9,"HRL":0.9,"HPE":0.9,"CRM":0.9,"XPEV":0.9,"CRWD":0.9,"WDAY":0.9}},"isVote":1,"tweetType":1,"viewCount":2450,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9962524090,"gmtCreate":1669811811810,"gmtModify":1676538248080,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Very nice&nbsp;","listText":"Very nice&nbsp;","text":"Very nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9962524090","repostId":"1196653595","repostType":4,"isVote":1,"tweetType":1,"viewCount":2904,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869297498,"gmtCreate":1632289287414,"gmtModify":1676530744192,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>good choice","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>good choice","text":"$Jamf Holding(JAMF)$good choice","images":[{"img":"https://static.tigerbbs.com/2bec5d783d6f5dc1e9882a1c3e45522b","width":"1080","height":"2116"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869297498","isVote":1,"tweetType":1,"viewCount":3026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":887626381,"gmtCreate":1632029677643,"gmtModify":1676530690083,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>take care","listText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>take care","text":"$Bilibili Inc.(BILI)$take care","images":[{"img":"https://static.tigerbbs.com/4383127dc3e619784952e0553445fb07","width":"1080","height":"2207"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/887626381","isVote":1,"tweetType":1,"viewCount":2669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":884195154,"gmtCreate":1631865050178,"gmtModify":1676530656024,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>good","listText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>good","text":"$MasterCard(MA)$good","images":[{"img":"https://static.tigerbbs.com/07bd0de52d7390900b4f63003a33ddd1","width":"1080","height":"2116"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884195154","isVote":1,"tweetType":1,"viewCount":2852,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":884195939,"gmtCreate":1631865043421,"gmtModify":1676530656008,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>good","listText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>good","text":"$MasterCard(MA)$good","images":[{"img":"https://static.tigerbbs.com/07bd0de52d7390900b4f63003a33ddd1","width":"1080","height":"2116"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884195939","isVote":1,"tweetType":1,"viewCount":2579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882511012,"gmtCreate":1631706255536,"gmtModify":1676530613588,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETCG\">$Grayscale Ethereum Classic Trust (ETC)(ETCG)$</a>good choice ?","listText":"<a href=\"https://laohu8.com/S/ETCG\">$Grayscale Ethereum Classic Trust (ETC)(ETCG)$</a>good choice ?","text":"$Grayscale Ethereum Classic Trust (ETC)(ETCG)$good choice ?","images":[{"img":"https://static.tigerbbs.com/3caf5bb4166ce18a785ffb7398747f0d","width":"1080","height":"2234"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882511012","isVote":1,"tweetType":1,"viewCount":2690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882932532,"gmtCreate":1631639360126,"gmtModify":1676530597885,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Nothing ?","listText":"Nothing ?","text":"Nothing ?","images":[{"img":"https://static.tigerbbs.com/9a644c82db1637fd4de505bc17369b1f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882932532","isVote":1,"tweetType":1,"viewCount":2831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":886258789,"gmtCreate":1631598560441,"gmtModify":1676530586110,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>ggood choice","listText":"<a href=\"https://laohu8.com/S/INTC\">$Intel(INTC)$</a>ggood choice","text":"$Intel(INTC)$ggood choice","images":[{"img":"https://static.tigerbbs.com/9b1f67ae83a7d4a6eaaccfbf7e205581","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/886258789","isVote":1,"tweetType":1,"viewCount":1040,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888573046,"gmtCreate":1631512784585,"gmtModify":1676530562316,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Nothing ?","listText":"Nothing ?","text":"Nothing ?","images":[{"img":"https://static.tigerbbs.com/9a644c82db1637fd4de505bc17369b1f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888573046","isVote":1,"tweetType":1,"viewCount":1208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888579901,"gmtCreate":1631512686503,"gmtModify":1676530562308,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wise choice to earn money","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wise choice to earn money","text":"$Jamf Holding(JAMF)$wise choice to earn money","images":[{"img":"https://static.tigerbbs.com/9af30fba2e67459e07d40c73388ac08b","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/888579901","isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888570439,"gmtCreate":1631512662821,"gmtModify":1676530562293,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wonderful choose ?","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wonderful choose ?","text":"$Jamf Holding(JAMF)$wonderful choose ?","images":[{"img":"https://static.tigerbbs.com/9af30fba2e67459e07d40c73388ac08b","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888570439","isVote":1,"tweetType":1,"viewCount":1137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888926449,"gmtCreate":1631424649281,"gmtModify":1676530546517,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"Nothing","listText":"Nothing","text":"Nothing","images":[{"img":"https://static.tigerbbs.com/9a644c82db1637fd4de505bc17369b1f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888926449","isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888928781,"gmtCreate":1631424535443,"gmtModify":1676530546492,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>good choice","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>good choice","text":"$Jamf Holding(JAMF)$good choice","images":[{"img":"https://static.tigerbbs.com/0481efee58365eeb9f66f84ea0cabdcc","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888928781","isVote":1,"tweetType":1,"viewCount":937,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881257492,"gmtCreate":1631350210916,"gmtModify":1676530534226,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SBUX\">$Starbucks(SBUX)$</a>first stock I invest with","listText":"<a href=\"https://laohu8.com/S/SBUX\">$Starbucks(SBUX)$</a>first stock I invest with","text":"$Starbucks(SBUX)$first stock I invest with","images":[{"img":"https://static.tigerbbs.com/60a8e668a6b41b431294f99b5a754cbc","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881257492","isVote":1,"tweetType":1,"viewCount":942,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881382565,"gmtCreate":1631293245457,"gmtModify":1676530523234,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>ggood choice to earn moneyWhat do you think?","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>ggood choice to earn moneyWhat do you think?","text":"$Jamf Holding(JAMF)$ggood choice to earn moneyWhat do you think?","images":[{"img":"https://static.tigerbbs.com/2c3b839e4562432d14dfaf8481b33b2d","width":"1080","height":"2234"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881382565","isVote":1,"tweetType":1,"viewCount":1099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":889085646,"gmtCreate":1631092058085,"gmtModify":1676530465333,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>aas i said before, it's really wonderful choice to buyWhat do you think will happen today?I think it will going up again","listText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>aas i said before, it's really wonderful choice to buyWhat do you think will happen today?I think it will going up again","text":"$Bilibili Inc.(BILI)$aas i said before, it's really wonderful choice to buyWhat do you think will happen today?I think it will going up again","images":[{"img":"https://static.tigerbbs.com/785040c5f8a92142f262604fabc7129e","width":"1080","height":"2416"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/889085646","isVote":1,"tweetType":1,"viewCount":1063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":880907860,"gmtCreate":1631005506050,"gmtModify":1676530440275,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582710052830337","idStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>very good choice to earn moneyDo you think that it will raise again today or no, and why?For high experience minded ?","listText":"<a href=\"https://laohu8.com/S/BILI\">$Bilibili Inc.(BILI)$</a>very good choice to earn moneyDo you think that it will raise again today or no, and why?For high experience minded ?","text":"$Bilibili Inc.(BILI)$very good choice to earn moneyDo you think that it will raise again today or no, and why?For high experience minded ?","images":[{"img":"https://static.tigerbbs.com/2a6e68de021206cbe8ec8a2dbcb02b0f","width":"1080","height":"2416"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880907860","isVote":1,"tweetType":1,"viewCount":1621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":836297180,"gmtCreate":1629496250640,"gmtModify":1676530057156,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"That's wonderful ?","listText":"That's wonderful ?","text":"That's wonderful ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836297180","repostId":"2160710721","repostType":4,"isVote":1,"tweetType":1,"viewCount":719,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836294431,"gmtCreate":1629496185123,"gmtModify":1676530057134,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"That's wonderful","listText":"That's wonderful","text":"That's wonderful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836294431","repostId":"1191201221","repostType":4,"isVote":1,"tweetType":1,"viewCount":520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836825048,"gmtCreate":1629471058484,"gmtModify":1676530052958,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/836825048","repostId":"2160105657","repostType":4,"isVote":1,"tweetType":1,"viewCount":854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111334556,"gmtCreate":1622651890275,"gmtModify":1704188242237,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/111334556","repostId":"1190877618","repostType":4,"repost":{"id":"1190877618","kind":"news","pubTimestamp":1622646647,"share":"https://ttm.financial/m/news/1190877618?lang=en_US&edition=fundamental","pubTime":"2021-06-02 23:10","market":"us","language":"en","title":"Zoom Earnings Beat Expectations: 5 Key Metrics You Should See","url":"https://stock-news.laohu8.com/highlight/detail?id=1190877618","media":"Motley Fool","summary":"The videoconferencing specialist also raised its full-year outlook.","content":"<p><b>Zoom Video Communications</b>&nbsp;(NASDAQ:ZM)&nbsp;reported powerful results for its first quarter of fiscal 2022, which ended on April 30. The videoconferencing specialist's business continued to get a tailwind from the COVID-19 pandemic, which has driven a surge in the number of people using its services for working, learning, and socializing from home.</p>\n<p>Shares of Zoom (which&nbsp;went public&nbsp;in April 2019) are up 2.8% on Wednesday as of 9:35 a.m. EDT. We can attribute the market's initial positive reaction to both revenue and earnings handily beating the Wall Street consensus estimates, fiscal Q2 guidance for both the top and bottom lines also easily surpassing analysts' expectations, and management raising its full-year outlook for both revenue and earnings.</p>\n<p>The market's reaction is muted because while year-over-year growth is still strong, it's slowing and expected to continue to slow. As I wrote in my&nbsp;earnings preview, this \"report marks Zoom's last relatively easy year-over-year comparable. It covers the period from February through April, so the year-ago period includes only about one and a half months that got a boost from the pandemic.\"</p>\n<p>Below is an overview of Zoom's quarter, along with its outlook.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/966adfe1ca445c638f2694f4b31d4801\" tg-width=\"2000\" tg-height=\"1142\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Revenue jumped 191%</b></p>\n<p>Zoom's fiscal first-quarter sales soared 191% year over year (and 8.4% from the prior quarter) to $956.2 million. This result sped by the $905.7 million analysts were expecting and the company's guidance of $900 million to $905 million. Growth was driven by the addition of new customers and expansion of the services the company provides to existing customers.</p>\n<p>For context, in the prior two quarters, Zoom's revenue surged 369% (fourth quarter of fiscal 2021) and 367% (third quarter of fiscal 2021) year over year. For the full fiscal year 2021, revenue rocketed 326% year over year to $2.65 billion.</p>\n<p>Here's a look at key customer metrics:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5697cb46c57d25575c9631bc374bfa72\" tg-width=\"1151\" tg-height=\"431\"><span>DATA SOURCE: ZOOM VIDEO COMMUNICATIONS. YOY = YEAR OVER YEAR.</span></p>\n<p>For context, last quarter, the number of customers with more than 10 employees skyrocketed 470% year over year to 467,000, and the number of customers contributing more than $100,000 in trailing-12-month revenue jumped 156% to 1,644.</p>\n<p>While year-over-year growth in the first metric is slowing, this is not the case with the second metric, whose year-over-year growth was about the same as last quarter.</p>\n<p><b>2. Adjusted operating income soared 634%</b></p>\n<p>Income from operations under generally accepted accounting principles (GAAP) was $226.3 million, a nearly tenfold increase from the year-ago period. Adjusted for one-time items, operating income came in at $400.9 million, up 634% year over year.</p>\n<p><b>3. Adjusted EPS surged 560%</b></p>\n<p>GAAP net income was $227.4 million, or $0.74 per share, up from $0.09 per share in the year-ago period. Adjusted net income landed at $402.1 million, or $1.32 per share, up 560% year over year.</p>\n<p>Wall Street had been looking for adjusted earnings per share (EPS) of $0.99, so the company easily beat the profit expectation. It also zoomed by its own guidance of $0.95 to $0.97.</p>\n<p><b>4. Operating cash flow rose 106%</b></p>\n<p>In fiscal Q1, operating cash flow grew 106% year over year to $533.3 million. Free cash flow increased 80% to $454.2 million.</p>\n<p>The company ended the period with $4.7 billion in available cash, cash equivalents, and marketable securities.</p>\n<p><b>5. Fiscal 2022 revenue is expected to jump about 50%</b></p>\n<p>For the second quarter of fiscal 2022, Zoom management guided for revenue between $985 million and $990 million, representing growth of 49% year over year at the midpoint. It also expects adjusted EPS of $1.14 to $1.15, representing growth of 24% to 25%.</p>\n<p>Going into the report, Wall Street had been modeling for fiscal Q2 adjusted EPS of $0.94 on revenue of $931.6 million. So Zoom's outlook on both the top and bottom lines breezed by analysts' expectations.</p>\n<p>For full-year fiscal 2022, management raised its guidance as follows:</p>\n<ul>\n <li>Revenue of $3.975 billion to $3.99 billion, up from the prior range of $3.76 billion to $3.78 billion.</li>\n <li>Adjusted EPS of $4.56 to $4.61, up from $3.59 to $3.65.</li>\n</ul>\n<p>The current full-year outlook represents expected annual revenue growth of 50% to 51% and adjusted EPS growth of 37% to 38%.</p>\n<p><b>Another fantastic quarter</b></p>\n<p>Zoom turned in fantastic Q1 results. Naturally, the company's year-over-year growth should slow as its comparables become extremely tough starting in Q2. Moreover, the fact that the pandemic is easing will likely hurt growth to some degree, but the company still has much long-term growth potential.</p>\n<p>Investors should be heartened by the solid Q2 outlook, keeping in mind the company has a track record of easily beating its guidance. In other words, it's probably safe to say that we can expect Q2 revenue growth of more than 49% and adjusted EPS growth of more than 25% year over year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zoom Earnings Beat Expectations: 5 Key Metrics You Should See</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZoom Earnings Beat Expectations: 5 Key Metrics You Should See\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 23:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/02/zoom-earnings-beat-expectations-5-key-metrics-you/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zoom Video Communications (NASDAQ:ZM) reported powerful results for its first quarter of fiscal 2022, which ended on April 30. The videoconferencing specialist's business continued to get a tailwind ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/02/zoom-earnings-beat-expectations-5-key-metrics-you/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2021/06/02/zoom-earnings-beat-expectations-5-key-metrics-you/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190877618","content_text":"Zoom Video Communications (NASDAQ:ZM) reported powerful results for its first quarter of fiscal 2022, which ended on April 30. The videoconferencing specialist's business continued to get a tailwind from the COVID-19 pandemic, which has driven a surge in the number of people using its services for working, learning, and socializing from home.\nShares of Zoom (which went public in April 2019) are up 2.8% on Wednesday as of 9:35 a.m. EDT. We can attribute the market's initial positive reaction to both revenue and earnings handily beating the Wall Street consensus estimates, fiscal Q2 guidance for both the top and bottom lines also easily surpassing analysts' expectations, and management raising its full-year outlook for both revenue and earnings.\nThe market's reaction is muted because while year-over-year growth is still strong, it's slowing and expected to continue to slow. As I wrote in my earnings preview, this \"report marks Zoom's last relatively easy year-over-year comparable. It covers the period from February through April, so the year-ago period includes only about one and a half months that got a boost from the pandemic.\"\nBelow is an overview of Zoom's quarter, along with its outlook.\nIMAGE SOURCE: GETTY IMAGES.\n1. Revenue jumped 191%\nZoom's fiscal first-quarter sales soared 191% year over year (and 8.4% from the prior quarter) to $956.2 million. This result sped by the $905.7 million analysts were expecting and the company's guidance of $900 million to $905 million. Growth was driven by the addition of new customers and expansion of the services the company provides to existing customers.\nFor context, in the prior two quarters, Zoom's revenue surged 369% (fourth quarter of fiscal 2021) and 367% (third quarter of fiscal 2021) year over year. For the full fiscal year 2021, revenue rocketed 326% year over year to $2.65 billion.\nHere's a look at key customer metrics:\nDATA SOURCE: ZOOM VIDEO COMMUNICATIONS. YOY = YEAR OVER YEAR.\nFor context, last quarter, the number of customers with more than 10 employees skyrocketed 470% year over year to 467,000, and the number of customers contributing more than $100,000 in trailing-12-month revenue jumped 156% to 1,644.\nWhile year-over-year growth in the first metric is slowing, this is not the case with the second metric, whose year-over-year growth was about the same as last quarter.\n2. Adjusted operating income soared 634%\nIncome from operations under generally accepted accounting principles (GAAP) was $226.3 million, a nearly tenfold increase from the year-ago period. Adjusted for one-time items, operating income came in at $400.9 million, up 634% year over year.\n3. Adjusted EPS surged 560%\nGAAP net income was $227.4 million, or $0.74 per share, up from $0.09 per share in the year-ago period. Adjusted net income landed at $402.1 million, or $1.32 per share, up 560% year over year.\nWall Street had been looking for adjusted earnings per share (EPS) of $0.99, so the company easily beat the profit expectation. It also zoomed by its own guidance of $0.95 to $0.97.\n4. Operating cash flow rose 106%\nIn fiscal Q1, operating cash flow grew 106% year over year to $533.3 million. Free cash flow increased 80% to $454.2 million.\nThe company ended the period with $4.7 billion in available cash, cash equivalents, and marketable securities.\n5. Fiscal 2022 revenue is expected to jump about 50%\nFor the second quarter of fiscal 2022, Zoom management guided for revenue between $985 million and $990 million, representing growth of 49% year over year at the midpoint. It also expects adjusted EPS of $1.14 to $1.15, representing growth of 24% to 25%.\nGoing into the report, Wall Street had been modeling for fiscal Q2 adjusted EPS of $0.94 on revenue of $931.6 million. So Zoom's outlook on both the top and bottom lines breezed by analysts' expectations.\nFor full-year fiscal 2022, management raised its guidance as follows:\n\nRevenue of $3.975 billion to $3.99 billion, up from the prior range of $3.76 billion to $3.78 billion.\nAdjusted EPS of $4.56 to $4.61, up from $3.59 to $3.65.\n\nThe current full-year outlook represents expected annual revenue growth of 50% to 51% and adjusted EPS growth of 37% to 38%.\nAnother fantastic quarter\nZoom turned in fantastic Q1 results. Naturally, the company's year-over-year growth should slow as its comparables become extremely tough starting in Q2. Moreover, the fact that the pandemic is easing will likely hurt growth to some degree, but the company still has much long-term growth potential.\nInvestors should be heartened by the solid Q2 outlook, keeping in mind the company has a track record of easily beating its guidance. In other words, it's probably safe to say that we can expect Q2 revenue growth of more than 49% and adjusted EPS growth of more than 25% year over year.","news_type":1,"symbols_score_info":{"ZM":0.9}},"isVote":1,"tweetType":1,"viewCount":1028,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111014655,"gmtCreate":1622644223077,"gmtModify":1704187979791,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"Wonderful ?","listText":"Wonderful ?","text":"Wonderful ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/111014655","repostId":"1188552613","repostType":4,"repost":{"id":"1188552613","kind":"news","pubTimestamp":1622627641,"share":"https://ttm.financial/m/news/1188552613?lang=en_US&edition=fundamental","pubTime":"2021-06-02 17:54","market":"us","language":"en","title":"AMC Stock Is Surging Again. How to Make Sense of the Move.","url":"https://stock-news.laohu8.com/highlight/detail?id=1188552613","media":"Barrons","summary":"AMC Entertainment‘s skyrocketing stock price would be easy to dismiss as just meme-trade madness, th","content":"<p>AMC Entertainment‘s skyrocketing stock price would be easy to dismiss as just meme-trade madness, that social media-fueled investor frenzy that has launched the likes of&nbsp;GameStop&nbsp;and&nbsp;BlackBerry&nbsp;into speculative territory.</p>\n<p>But it’s possible that traditional investors have missed a fundamental change in the movie theater business—and it wouldn’t be the first time.</p>\n<p>Shares of AMC (ticker: AMC) surged 23% on Tuesday, closing at $32.04—just off an all-time high of $36.72 set in late May. That puts the movie-theater chain’s market capitalization at roughly $16 billion, more than 15 times what it was in 2018, a record-breaking year at the box office.&nbsp;Shares were up another 34%, to $42.92, in premarket trading Wednesday.</p>\n<p>Even if investors missed an inflection point, though, the math doesn’t add up. The reason might be that market cap isn’t the right measure. Maybe it’s enterprise value, which is essentially market cap and debt. AMC’s enterprise value is about $26 billion, compared with $6.2 billion or so at the end of 2018.</p>\n<p>AMC added debt during the pandemic as theaters in the country’s biggest cities were dark for months. And the numbers make it easy to understand why: The U.S. box office in 2020 generated about $2.1 billion in ticket sales, down 81% from the 2018 record of $11.9 billion.</p>\n<p>So, it seems investors have been vexed by movie theater economics. But it wouldn’t be the first time. The industry essentially went belly up at the turn of the millennium. Regal Cinemas, for instance, declared bankruptcy in 2001.</p>\n<p>Back then, the industry had plenty of capacity because of a new theater design—stadium seating that gave a better view of the screen. That shift meant movie theater chains had to renovate or risk losing all their patrons to movie theaters that offered the better view. In the end, too many seats and not enough patrons meant the return on the stadium-seating investments never materialized.</p>\n<p>The upshot was consolidation. With fewer operators, the number of screens stabilized. Between 2002 and 2007, Regal Cinemas became a cash-generating machine because the stock was mispriced. The stock returned 21% a year on average. The S&amp;P 500 and Dow Jones Industrial Average both returned less than 9% a year on average over the same period.</p>\n<p>In those days, Regal Cinema’s enterprise value about $5 billion, or about 50% of total U.S. box office sales. That’s far short of AMC today. Something new has to be different for AMC to be worth it.</p>\n<p>Maybe the movie theater business is going to go through another period of consolidation, which can usher in another golden age of returns. AMC’s Tuesday gains, in fact, were catalyzed by new capital raised so the company could go on the offensive, acquiring defunct chains. Monopolies, after all, can be good for stock returns.</p>\n<p>If AMC can increase market share and the U.S. box office sales can return to 2018 levels in a few years, total sales at might be $9 billion—$6 billion from tickets and $3 billion from concessions. Sales in 2018 amounted to $5.5 billion.</p>\n<p>Then, with better gross profit margins derived from larger scale, AMC might be able to generate $600 million in free cash flow annually, which puts the stock at about a 4% free cash flow yield. The S&amp;P 500 trades for about a 3% free cash flow yield. The numbers can work—if they’re stretched.</p>\n<p>There are problems with this scenario, though. There are lots of ifs and mights—and AMC has never generated cash flow like that in the past. Arriving at $600 million in free cash flow is more about justifying current valuations than predicting what is likely.</p>\n<p>Also, with mergers and acquisitions, AMC market shares might rise, but there are still competitors. Regal Cinemas is still out there, owned by Cineworld Holdings (CINE. London). So is Cinemark (CNK). There’s not a true monopoly.</p>\n<p>AMC and its peers have to deal with streaming, too. Windows for exclusive theater showings are shrinking. The pandemic has accelerated that. And if AMC gets too large and demanding for movie makers, the talent can always go to streaming faster, hurting box office sales.</p>\n<p>There is also the problem of the peer stocks. They aren’t trading like this is a brave new world for theaters. Cineworld stock is up 484% from its 52-week low, but shares are still off 72% from all-time highs. Cinemark shares are up 222% from their 52-week low. They are down 47% from their all-time high.</p>\n<p>AMC stock, again, is up almost 1,600% from its 52-week low and is down just 13% from its May all-time high.</p>\n<p>Wall Street just doesn’t see the potential either. Nine analysts cover the stock. The average analyst price target is about $5. Before the pandemic, the average analyst price target was $15. But there were fewer shares back then. The old target enterprise value was roughly $7 billion. It’s tough to get from $7 billion to $26 billion predicting better margins.</p>\n<p>Analysts do have positive free cash flow modeled, though–$13 million in 2022 and $90 million in 2023. That’s a long way from $600 million.</p>\n<p>And that’s just another way of saying that AMC bulls are a long way from making the math work.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Stock Is Surging Again. How to Make Sense of the Move.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Stock Is Surging Again. How to Make Sense of the Move.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 17:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/amc-rockets-higher-is-it-worth-it-maybe-51622594691?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AMC Entertainment‘s skyrocketing stock price would be easy to dismiss as just meme-trade madness, that social media-fueled investor frenzy that has launched the likes of GameStop and BlackBerry into ...</p>\n\n<a href=\"https://www.barrons.com/articles/amc-rockets-higher-is-it-worth-it-maybe-51622594691?mod=hp_LEAD_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.barrons.com/articles/amc-rockets-higher-is-it-worth-it-maybe-51622594691?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188552613","content_text":"AMC Entertainment‘s skyrocketing stock price would be easy to dismiss as just meme-trade madness, that social media-fueled investor frenzy that has launched the likes of GameStop and BlackBerry into speculative territory.\nBut it’s possible that traditional investors have missed a fundamental change in the movie theater business—and it wouldn’t be the first time.\nShares of AMC (ticker: AMC) surged 23% on Tuesday, closing at $32.04—just off an all-time high of $36.72 set in late May. That puts the movie-theater chain’s market capitalization at roughly $16 billion, more than 15 times what it was in 2018, a record-breaking year at the box office. Shares were up another 34%, to $42.92, in premarket trading Wednesday.\nEven if investors missed an inflection point, though, the math doesn’t add up. The reason might be that market cap isn’t the right measure. Maybe it’s enterprise value, which is essentially market cap and debt. AMC’s enterprise value is about $26 billion, compared with $6.2 billion or so at the end of 2018.\nAMC added debt during the pandemic as theaters in the country’s biggest cities were dark for months. And the numbers make it easy to understand why: The U.S. box office in 2020 generated about $2.1 billion in ticket sales, down 81% from the 2018 record of $11.9 billion.\nSo, it seems investors have been vexed by movie theater economics. But it wouldn’t be the first time. The industry essentially went belly up at the turn of the millennium. Regal Cinemas, for instance, declared bankruptcy in 2001.\nBack then, the industry had plenty of capacity because of a new theater design—stadium seating that gave a better view of the screen. That shift meant movie theater chains had to renovate or risk losing all their patrons to movie theaters that offered the better view. In the end, too many seats and not enough patrons meant the return on the stadium-seating investments never materialized.\nThe upshot was consolidation. With fewer operators, the number of screens stabilized. Between 2002 and 2007, Regal Cinemas became a cash-generating machine because the stock was mispriced. The stock returned 21% a year on average. The S&P 500 and Dow Jones Industrial Average both returned less than 9% a year on average over the same period.\nIn those days, Regal Cinema’s enterprise value about $5 billion, or about 50% of total U.S. box office sales. That’s far short of AMC today. Something new has to be different for AMC to be worth it.\nMaybe the movie theater business is going to go through another period of consolidation, which can usher in another golden age of returns. AMC’s Tuesday gains, in fact, were catalyzed by new capital raised so the company could go on the offensive, acquiring defunct chains. Monopolies, after all, can be good for stock returns.\nIf AMC can increase market share and the U.S. box office sales can return to 2018 levels in a few years, total sales at might be $9 billion—$6 billion from tickets and $3 billion from concessions. Sales in 2018 amounted to $5.5 billion.\nThen, with better gross profit margins derived from larger scale, AMC might be able to generate $600 million in free cash flow annually, which puts the stock at about a 4% free cash flow yield. The S&P 500 trades for about a 3% free cash flow yield. The numbers can work—if they’re stretched.\nThere are problems with this scenario, though. There are lots of ifs and mights—and AMC has never generated cash flow like that in the past. Arriving at $600 million in free cash flow is more about justifying current valuations than predicting what is likely.\nAlso, with mergers and acquisitions, AMC market shares might rise, but there are still competitors. Regal Cinemas is still out there, owned by Cineworld Holdings (CINE. London). So is Cinemark (CNK). There’s not a true monopoly.\nAMC and its peers have to deal with streaming, too. Windows for exclusive theater showings are shrinking. The pandemic has accelerated that. And if AMC gets too large and demanding for movie makers, the talent can always go to streaming faster, hurting box office sales.\nThere is also the problem of the peer stocks. They aren’t trading like this is a brave new world for theaters. Cineworld stock is up 484% from its 52-week low, but shares are still off 72% from all-time highs. Cinemark shares are up 222% from their 52-week low. They are down 47% from their all-time high.\nAMC stock, again, is up almost 1,600% from its 52-week low and is down just 13% from its May all-time high.\nWall Street just doesn’t see the potential either. Nine analysts cover the stock. The average analyst price target is about $5. Before the pandemic, the average analyst price target was $15. But there were fewer shares back then. The old target enterprise value was roughly $7 billion. It’s tough to get from $7 billion to $26 billion predicting better margins.\nAnalysts do have positive free cash flow modeled, though–$13 million in 2022 and $90 million in 2023. That’s a long way from $600 million.\nAnd that’s just another way of saying that AMC bulls are a long way from making the math work.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836230843,"gmtCreate":1629496508782,"gmtModify":1676530057167,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"I think that's totally right","listText":"I think that's totally right","text":"I think that's totally right","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/836230843","repostId":"2160710910","repostType":4,"isVote":1,"tweetType":1,"viewCount":739,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836684468,"gmtCreate":1629476452954,"gmtModify":1676530055357,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"That's good","listText":"That's good","text":"That's good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836684468","repostId":"1129576857","repostType":4,"isVote":1,"tweetType":1,"viewCount":574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805590180,"gmtCreate":1627889228040,"gmtModify":1703497252001,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"That's really good ?","listText":"That's really good ?","text":"That's really good ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/805590180","repostId":"2156169743","repostType":4,"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167644763,"gmtCreate":1624267555452,"gmtModify":1703831977911,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/167644763","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://ttm.financial/m/news/1184501396?lang=en_US&edition=fundamental","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888579901,"gmtCreate":1631512686503,"gmtModify":1676530562308,"author":{"id":"3582710052830337","authorId":"3582710052830337","name":"semsem","avatar":"https://static.tigerbbs.com/5b9f05e7dbe5d400cc4455ee79b32617","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3582710052830337","authorIdStr":"3582710052830337"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wise choice to earn money","listText":"<a href=\"https://laohu8.com/S/JAMF\">$Jamf Holding(JAMF)$</a>wise choice to earn money","text":"$Jamf Holding(JAMF)$wise choice to earn money","images":[{"img":"https://static.tigerbbs.com/9af30fba2e67459e07d40c73388ac08b","width":"1080","height":"2325"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/888579901","isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}